Benjawan Khuntirat1, Christopher S Love2, Darunee Buddhari3, Gary L Heil4, Robert V Gibbons3, Alan L Rothman5, Anon Srikiatkhachorn6, Gregory C Gray4, In-Kyu Yoon3. 1. Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. Electronic address: BenjawanK@afrims.org. 2. Naval Medical Center Portsmouth, Portsmouth, VA, USA. 3. Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. 4. College of Public Health and Health Professions and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA. 5. Institute for Immunology and Informatics, University of Rhode Island, Providence, Rhode Island, USA. 6. Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Abstract
BACKGROUND: Influenza A/H5N1 actively circulated in Kamphaeng Phet (KPP), Thailand from 2004 to 2006. A prospective longitudinal cohort study of influenza virus infection in 800 adults conducted during 2008-2010 in KPP suggested that subclinical or mild H5N1 infections had occurred among this adult cohort. However, this study was conducted after the peak of H5N1 activity in KPP. Coincidentally, banked serum samples were available from a prospective longitudinal cohort study of primary school children who had undergone active surveillance for febrile illnesses from 2004 to 2007 and lived in the same district of KPP as the adult cohort. OBJECTIVES: We sought to investigate whether subclinical or mild H5N1 infections had occurred among KPP residents during the peak of H5N1 activity from 2004 to 2006. STUDY DESIGN: H5N1 microneutralization (MN) assay was performed on banked serum samples from a prospective longitudinal cohort study of primary school children who had undergone active surveillance for febrile illnesses in KPP. Annual blood samples collected from 2004 to 2006 from 251 children were selected based on the criteria that they lived in villages with documented H5N1 infection. RESULT: No H5N1 neutralizing antibodies were detected in 753 annual blood samples from 251 children. CONCLUSION: During 2004-2006, very few subclinical or mild H5N1 infections occurred in KPP. Elevated H5N1 MN titers found in the adult cohort in 2008 were likely due to cross-reactivity from other influenza virus subtypes highlighting the complexities in interpreting influenza serological data. Published by Elsevier B.V.
BACKGROUND:InfluenzaA/H5N1 actively circulated in Kamphaeng Phet (KPP), Thailand from 2004 to 2006. A prospective longitudinal cohort study of influenza virus infection in 800 adults conducted during 2008-2010 in KPP suggested that subclinical or mild H5N1 infections had occurred among this adult cohort. However, this study was conducted after the peak of H5N1 activity in KPP. Coincidentally, banked serum samples were available from a prospective longitudinal cohort study of primary school children who had undergone active surveillance for febrile illnesses from 2004 to 2007 and lived in the same district of KPP as the adult cohort. OBJECTIVES: We sought to investigate whether subclinical or mild H5N1 infections had occurred among KPP residents during the peak of H5N1 activity from 2004 to 2006. STUDY DESIGN:H5N1 microneutralization (MN) assay was performed on banked serum samples from a prospective longitudinal cohort study of primary school children who had undergone active surveillance for febrile illnesses in KPP. Annual blood samples collected from 2004 to 2006 from 251 children were selected based on the criteria that they lived in villages with documented H5N1infection. RESULT: No H5N1 neutralizing antibodies were detected in 753 annual blood samples from 251 children. CONCLUSION: During 2004-2006, very few subclinical or mild H5N1 infections occurred in KPP. Elevated H5N1 MN titers found in the adult cohort in 2008 were likely due to cross-reactivity from other influenza virus subtypes highlighting the complexities in interpreting influenza serological data. Published by Elsevier B.V.
Authors: Benjawan P Khuntirat; In-Kyu Yoon; Patrick J Blair; Whitney S Krueger; Malinee Chittaganpitch; Shannon D Putnam; Krongkaew Supawat; Robert V Gibbons; Sirima Pattamadilok; Pathom Sawanpanyalert; Gary L Heil; John A Friary; Ana W Capuano; Gregory C Gray Journal: Clin Infect Dis Date: 2011-10 Impact factor: 9.079
Authors: Philippe Buchy; Sirenda Vong; Simon Chu; Jean-Michel Garcia; Tran Tinh Hien; Vo Minh Hien; Mey Channa; Do Quang Ha; Nguyen Van Vinh Chau; Cameron Simmons; Jeremy J Farrar; Malik Peiris; Menno D de Jong Journal: PLoS One Date: 2010-05-27 Impact factor: 3.240
Authors: Whitney S Krueger; Benjawan Khuntirat; In-Kyu Yoon; Patrick J Blair; Malinee Chittagarnpitch; Shannon D Putnam; Krongkaew Supawat; Robert V Gibbons; Darunee Bhuddari; Sirima Pattamadilok; Pathom Sawanpanyalert; Gary L Heil; Gregory C Gray Journal: PLoS One Date: 2013-08-16 Impact factor: 3.240
Authors: Mai Quynh Le; Peter Horby; Annette Fox; Hien Tran Nguyen; Hang Khanh Le Nguyen; Phuong Mai Vu Hoang; Khanh Cong Nguyen; Menno D de Jong; Rienk E Jeeninga; H Rogier van Doorn; Jeremy Farrar; Heiman F L Wertheim Journal: Emerg Infect Dis Date: 2013-10 Impact factor: 6.883
Authors: Xinhua Chen; Wei Wang; Yan Wang; Shengjie Lai; Juan Yang; Benjamin J Cowling; Peter W Horby; Timothy M Uyeki; Hongjie Yu Journal: BMC Med Date: 2020-12-02 Impact factor: 8.775
Authors: Julia Roider; Takashi Maehara; Abigail Ngoepe; Duran Ramsuran; Maximilian Muenchhoff; Emily Adland; Toby Aicher; Samuel W Kazer; Pieter Jooste; Farina Karim; Warren Kuhn; Alex K Shalek; Thumbi Ndung'u; Lynn Morris; Penny L Moore; Shiv Pillai; Henrik Kløverpris; Philip Goulder; Alasdair Leslie Journal: Front Immunol Date: 2018-09-12 Impact factor: 7.561